DAAAAMN, Big Pharma, back at it again with the price gouging!

This week, drug manufacturer Novum Pharma jacked up the price of one of its acne creams, Aloquin, to $9,561 — a 128% hike from its previous cost.

Aloquin's new price tag is especially mind boggling, considering the generic version sells for roughly $30.

Many are accusing Novum Pharma of price gouging, a dangerous trend among drug manufacturers.

Companies like Turig Pharmaceuticals (formerly helmed by Martin Shkreli) and more recently, Epipen manufacturer Myla, have come under fire for increasing their prices to exorbitant amounts.

While drug companies profit enormously off this, those who rely on the drugs pay a hefty price in more ways than one.

On top of that, according to Novum Pharma's website, the U.S.Food and Drug Administration (FDA) has deemed Aloquin "possibly effective," meaning there's little evidence to prove it works as it's intended to.

That hasn't stopped Novum from jumping on the gauging trend.

The manufacturer has also increased the prices of its other creams, Alcortin A and Novacort, by thousands of dollars. Because reasons.

Naturally, everyone's confused.

"From a clinical standpoint, a drug listed as 'possibly effective' by the FDA, shouldn't be a likely treatment choice by doctors — especially not with a $10,000 price tag," Michael Rea, chief executive of Rx Savings Solutions told CNBC.

Revelist has reached out to Novum Pharma for comment.